In their Joint Response to a consultation by the US Institute of Medicine (IOM), HAI Europe, ISDB, MiEF and TACD encourage the active implementation of a data sharing policy that ensures full public access to clinical data in the US, in alignment with the new European requirements.
A report by the civil society partners shows that the pharmaceutical industry's wish list for the Transatlantic Trade and Investment Partnership (TTIP) is detrimental for public health, will increase the cost of medicines and undermines democratic processes.
The November 2014 issue of the ISDB Newsletter (vol 29, issue 2) includes:
- preliminary announcement of the ISDB General Assembly, scheduled to take place in Pamplona, Spain in June 2015
- draft program for the 2015 ISDB General Assembly